The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trends over time in liquid biopsy testing in patients with metastatic breast cancer (MBC) across the Mayo Clinic enterprise.
 
Sumeet Kumar Yadav
No Relationships to Disclose
 
Sanjna Rajput
No Relationships to Disclose
 
Thoshik Samineni
No Relationships to Disclose
 
Kevin Thompson
No Relationships to Disclose
 
Xiaojia Tang
No Relationships to Disclose
 
Roberto Antonio Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lyell Immunopharma (Inst)
 
Ciara Catherine O'Sullivan
Honoraria - AstraZeneca (Inst); Medscape (Inst); Seagen (Inst); Seagen (Inst)
Research Funding - Academic & Community Cancer Research United (Inst); Bavarian Nordic (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); nference (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - nFerence Astra Zeneca (Inst)
 
Prema P. Peethambaram
No Relationships to Disclose
 
Pooja Prem Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I)
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); BMS (I); Puma Biotechnology
Research Funding - Agendia; Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche; Gilead Sciences (Inst); Seagan (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
Kostandinos Sideras
No Relationships to Disclose
 
Saranya Chumsri
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; bioTheranostics; bioTheranostics (Inst); Eisai; Immunomedics; Immunomedics; Immunomedics; Novartis; Novartis; Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Merck; Salix
 
Paula Gill
No Relationships to Disclose
 
Jonathan Ticku
Employment - Mayo Clinic Health Syste
Honoraria - Curio Science; Curio Science; DAVA oncolgy
Consulting or Advisory Role - Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health
 
Karen S. Anderson
Stock and Other Ownership Interests - FlexBioTech
Consulting or Advisory Role - eFFECTOR Therapeutics
Patents, Royalties, Other Intellectual Property - Own patents and pending patents; no company
 
Brenda Ernst
No Relationships to Disclose
 
Donald W. Northfelt
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Tufia C. Haddad
Consulting or Advisory Role - Puma Biotechnology (Inst)
Research Funding - Takeda (Inst)
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); BioTheryX; Blueprint Medicines (Inst); Engage Health Media (Inst); Genzyme (Inst); Laekna Therapeutics; Lilly (Inst); Novartis (Inst); Rna Diagnostics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly (Inst)
 
Krishna Rani Kalari
No Relationships to Disclose
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); MJH Live Events (Inst); MJH Live Events (Inst); NeoGenomics Laboratories (Inst); Puma Biotechnology (Inst); Tersera (Inst)
Research Funding - Guardant Health (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GRAIL; QuantumLeap Health